Picterus has developed a smartphone application that can screen for neonatal jaundice with high accuracy.
Picterus's investors include European Innovation Council, EIC Accelerator, EISMEA, CVX Ventures, Farvatn Venture.
Picterus is headquartered in Trondheim, Norway.
Picterus has developed a smartphone application that can screen for neonatal jaundice with high accuracy.
Picterus is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Picterus — Funding & Investors." VCBacked, June 19, 2023, https://www.vcbacked.co/company/picterus. Accessed August 15, 2026.
VCBacked. (2023). Picterus — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/picterus
{{cite web |title=Picterus — Funding & Investors |url=https://www.vcbacked.co/company/picterus |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated